01-10-2019 | Infliximab | Case report
Infliximab
Development of anti-infliximab antibodies, rash and fever: case report
Published in: Reactions Weekly | Issue 1/2019
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event